You are here: Industry Insights > BMJ

News List

Privacy Concerns Examined Regarding Use of Mobile Health Apps drugs
June 21, 2021
Most health-related mobile applications (mHealth apps) contain code that could potentially collect user data, according to a study published online June 16 in The BMJ.
BMJ journal deems opioid dependency implant more favourable than tablets pharmatimes
March 30, 2020
A new benefit-risk study published in the BMJ Evidence Based Medicine has deemed a new implant preventing withdrawal symptoms for patients with opioid dependency more favourable than sublingual tablets.
BMJ study shows correlation between processed foods and CV disease pharmatimes
June 03, 2019
According to a recently published report in the BMJ, higher consumption of ultra-processed foods is associated with higher risks of cardiovascular, coronary heart, and cerebrovascular diseases.
Habitual Glucosamine Use Linked to Reduced Risk for CVD Events drugs
May 16, 2019
Habitual Glucosamine Use Linked to Reduced Risk for CVD Events.
BMJ publishes subclinical hypothyroidism guideline pharmatimes
May 15, 2019
The BMJ has released a new clinical practice guideline evaluating the benefits and harms of thyroid hormones for adults with subclinical hypothyroidism (SCH), triggered by a recent systematic review of randomised controlled trials, which could alter pract
HPV vaccine to thank for 89% decline in cervical cancer pharmatimes
April 10, 2019
A new analysis has found that human papillomavirus (HPV) vaccination of 12 and 13 year old girls has led to an 89% decline in cases of cervical cancer in Scotland.
Researchers call for investigation into rising mortality rates pharmatimes
July 23, 2018
Researchers are calling for a government investigation into the “substantial increase” in mortality seen in early 2018 in England and Wales.
Research into clinical trial transparency shows huge variation in standards pharmafile
July 31, 2017
A study published in the BMJ displayed the large degree of variation and lack of industry-standard when it comes to revealing clinical trial data.